Last reviewed · How we verify
Vilanterol and Fluticasone Furoate — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Vilanterol and Fluticasone Furoate (Vilanterol and Fluticasone Furoate) — University of Saskatchewan.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Vilanterol and Fluticasone Furoate TARGET | Vilanterol and Fluticasone Furoate | University of Saskatchewan | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Vilanterol and Fluticasone Furoate CI watch — RSS
- Vilanterol and Fluticasone Furoate CI watch — Atom
- Vilanterol and Fluticasone Furoate CI watch — JSON
- Vilanterol and Fluticasone Furoate alone — RSS
Cite this brief
Drug Landscape (2026). Vilanterol and Fluticasone Furoate — Competitive Intelligence Brief. https://druglandscape.com/ci/vilanterol-and-fluticasone-furoate. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab